{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T08:33:14Z","timestamp":1670229194735},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,4,19]],"date-time":"2013-04-19T00:00:00Z","timestamp":1366329600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s10067-013-2261-z","type":"journal-article","created":{"date-parts":[[2013,4,18]],"date-time":"2013-04-18T02:47:24Z","timestamp":1366253244000},"page":"1191-1197","source":"Crossref","is-referenced-by-count":2,"title":["Achievement of clinical remission in patients with juvenile idiopathic arthritis under a 2\u201310-year Etanercept exposure"],"prefix":"10.1007","volume":"32","author":[{"given":"Maria","family":"Trachana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Polyxeni","family":"Pratsidou-Gertsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Badouraki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Bettina","family":"Haidich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grigoris","family":"Pardalos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,4,19]]},"reference":[{"key":"2261_CR1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.pcl.2012.03.014","volume":"59","author":"PJ Gowdie","year":"2012","unstructured":"Gowdie PJ, Tse SM (2012) Juvenile idiopathic arthritis. Pediatr Clin North Am 59:301\u2013327","journal-title":"Pediatr Clin North Am"},{"key":"2261_CR2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.7861\/clinmedicine.12-4-357","volume":"12","author":"NJ Gullick","year":"2012","unstructured":"Gullick NJ, Scott DL (2012) Drug therapy of inflammatory arthritis. Clin Med 12:357\u2013363","journal-title":"Clin Med"},{"key":"2261_CR3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1741-7015-10-59","volume":"10","author":"E Baildam","year":"2012","unstructured":"Baildam E (2012) A commentary on TREAT: the trial of early aggressive drug therapy in juvenile idiopathic arthritis. BMC Med 10:59","journal-title":"BMC Med"},{"key":"2261_CR4","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.20460","volume":"63","author":"T Beukelman","year":"2011","unstructured":"Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, DeWitt EM et al (2011) 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res 63:465\u2013482","journal-title":"Arthritis Care Res"},{"key":"2261_CR5","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/rheumatology\/kes019","volume":"51","author":"K Minden","year":"2012","unstructured":"Minden K, Niewerth M, Zink A, Seipelt E, Foeldvari I, Girschick H et al (2012) Long-term outcome of patients with JIA treated with etanercept, results of the biologic register JUMBO. Rheumatology (Oxford) 51:1407\u20131415","journal-title":"Rheumatology (Oxford)"},{"key":"2261_CR6","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/rheumatology\/keq292","volume":"50","author":"V Papsdorf","year":"2011","unstructured":"Papsdorf V, Horneff G (2011) Complete control of disease activity and remission induced by treatment with etanercept in juvenile idiopathic arthritis. Rheumatology 50:214\u2013221","journal-title":"Rheumatology"},{"key":"2261_CR7","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.3899\/jrheum.090952","volume":"36","author":"RAG Russo","year":"2009","unstructured":"Russo RAG, Katsikas MM (2009) Clinical remission in patients with systemic juvenile idiopathic arthritis treated with anti-tumor necrosis factor agents. J Rheumatol 36:1078\u20131082","journal-title":"J Rheumatol"},{"key":"2261_CR8","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/BOR.0b013e32825a6a68","volume":"19","author":"S Ringold","year":"2007","unstructured":"Ringold S, Wallace CA (2007) Measuring clinical response and remission in juvenile idiopathic arthritis. Curr Opin Rheumatol 19:471\u2013476","journal-title":"Curr Opin Rheumatol"},{"key":"2261_CR9","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J et al (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390\u2013392","journal-title":"J Rheumatol"},{"key":"2261_CR10","unstructured":"Greek Rheumatology Society. [Greek Rheumatology Society\u2019s recommendations for the treatment of rheumatic diseases with biologic agents]. [Article in Greek] www.ere.gr\/-Pdf\/ere-systaseis.pdf . accessed Feb 2005"},{"key":"2261_CR11","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/art.24516","volume":"61","author":"A Consolaro","year":"2009","unstructured":"Consolaro A, Ruperto N, Bazso A, Pistorio A, Magni-Manzoni S, Filocamo G et al (2009) Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum 61:658\u2013666","journal-title":"Arthritis Rheum"},{"key":"2261_CR12","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/1529-0131(199707)40:7<1202::AID-ART3>3.0.CO;2-R","volume":"40","author":"EH Giannini","year":"1997","unstructured":"Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A (1997) Preliminary definition of improvement in juvenile idiopathic arthritis. Arthritis Rheum 40:1202\u20131209","journal-title":"Arthritis Rheum"},{"issue":"suppl 23","key":"2261_CR13","first-page":"S76","volume":"19","author":"P Pratsidou-Gertsi","year":"2001","unstructured":"Pratsidou-Gertsi P, Vougiouka O, Tsitsami E, Ruperto N, Siamopoulou-Mavridou A, Dracou C et al (2001) The Greek version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol 19(suppl 23):S76\u2013S80","journal-title":"Clin Exp Rheumatol"},{"key":"2261_CR14","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1148\/129.3.661","volume":"129","author":"AK Poznanski","year":"1978","unstructured":"Poznanski AK, Hernandez RJ, Guire KE, Bereza U, Garn SN (1978) Carpal length in children\u2014a useful measurement in the diagnosis of rheumatoid arthritis and some congenital malformation syndromes. Radiology 129:661\u2013668","journal-title":"Radiology"},{"key":"2261_CR15","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1002\/art.21247","volume":"52","author":"MA Rossum van","year":"2005","unstructured":"van Rossum MA, Boers M, Zwinderman AH, van Soesbergen RM, Wieringa H, Fiselier TJ et al (2005) Arthritis Rheum 52:2865\u20132872","journal-title":"Arthritis Rheum"},{"key":"2261_CR16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1136\/ard.62.3.245","volume":"62","author":"P Lahdenne","year":"2003","unstructured":"Lahdenne P, Vahasalo P, Honkanen V (2003) Infliximab or Etanercept in the treatment of children with refractory juvenile idiopathic arthritis: an open label study. Ann Rheum Dis 62:245\u2013247","journal-title":"Ann Rheum Dis"},{"key":"2261_CR17","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1002\/art.21885","volume":"54","author":"DJ Lovell","year":"2006","unstructured":"Lovell DJ, Reiff A, Olcay Y, Schneider R, Nocton J, Stein LD et al (2006) Long-term safety and efficacy of etanercept in children with polyarticular course juvenile rheumatoid arthritis. Arthritis Rheum 54:1987\u20131994","journal-title":"Arthritis Rheum"},{"key":"2261_CR18","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1177\/0091270004273321","volume":"45","author":"H Zhou","year":"2005","unstructured":"Zhou H (2005) Clinical pharmacokinetics of Etanercept: a fully humanized soluble recombinant tumor necrosis factor receptor fusion protein. J Clin Pharmacol 45:490\u2013497","journal-title":"J Clin Pharmacol"},{"key":"2261_CR19","first-page":"919","volume":"28","author":"P Pratsidou-Gertsi","year":"2010","unstructured":"Pratsidou-Gertsi P, Trachana M, Pardalos G, Kanakoudi-Tsakalidou F (2010) A follow-up study of patients with juvenile idiopathic arthritis who discontinued etanercept due to disease remission. Clin Exp Rheumatol 28:919\u2013922","journal-title":"Clin Exp Rheumatol"},{"key":"2261_CR20","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1002\/art.34373","volume":"64","author":"A Consolaro","year":"2012","unstructured":"Consolaro A, Bracciolini G, Ruperto N, Pistorio A, Magni-Manzoni S, Malattia C et al (2012) Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis defining criteria based on the juvenile arthritis disease activity score. Arthr Rheum 64:2366\u20132374","journal-title":"Arthr Rheum"},{"key":"2261_CR21","doi-asserted-by":"crossref","first-page":"84","DOI":"10.5455\/apr.032920121140","volume":"1","author":"G Filocamo","year":"2012","unstructured":"Filocamo G, Consolaro A, Solari N, Palmisani E, Dalpr\u03b0 S, Suffia C et al (2012) Recent advances in quantitative assessment of juvenile idiopathic arthritis. Ann Paediatr Rheumatol 1:84\u201396","journal-title":"Ann Paediatr Rheumatol"},{"key":"2261_CR22","first-page":"579","volume":"30","author":"F Fantini","year":"2003","unstructured":"Fantini F, Gerloni V, Gattinara M, Cimaz R, Arnoldi C, Lupi E (2003) Remission in juvenile chronic arthritis: a cohort study of 683 consecutive cases with a mean 10 year follow up. J Rheumatol 30:579\u2013584","journal-title":"J Rheumatol"},{"key":"2261_CR23","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1002\/art.34343","volume":"64","author":"CA Wallace","year":"2012","unstructured":"Wallace CA, Giannini EH, Spalding SJ, Hashkes PJ, O\u2019Neil KM, Zeft AS et al (2012) Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis. Arthritis Rheum 64:2012\u20132021","journal-title":"Arthritis Rheum"},{"key":"2261_CR24","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1001\/jama.2011.1671","volume":"306","author":"MH Otten","year":"2011","unstructured":"Otten MH, Prince FHM, Armbrust W, ten Cate R, Hoppenreijs EPAH, Twilt M et al (2011) Factors associated with treatment response to etanercept in juvenile idiopathic arthritis. JAMA 306:2340\u20132347","journal-title":"JAMA"},{"key":"2261_CR25","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1002\/art.34373","volume":"64","author":"A Consolaro","year":"2012","unstructured":"Consolaro A, Bracciolini G, Ruperto N, Pistorio A, Magni-Manzoni S, Malattia C et al (2012) Remission, minimal disease activity and acceptable symptom state in juvenile idiopathic arthritis. Defining criteria based on the juvenile arthritis disease activity score. Arthritis Rheum 64:2366\u20132374","journal-title":"Arthritis Rheum"},{"key":"2261_CR26","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1136\/annrheumdis-2011-200358","volume":"71","author":"J Sieper","year":"2012","unstructured":"Sieper J, van der Heijde D, Dougados M, Brown LS, Lavie F, Pangan AL (2012) Early response to adalimumab predicts long-term remission through 5 years of treatment in patients with ankylosing spondylitis. Ann Rheum Dis 71:700\u2013706","journal-title":"Ann Rheum Dis"},{"key":"2261_CR27","first-page":"585","volume":"30","author":"K Oen","year":"2003","unstructured":"Oen K, Malleson PN, Cabral DA, Rosenberg AM, Petty RE, Reed M et al (2003) Early predictors of long term outcome in patients with juvenile rheumatoid arthritis: subset-specific correlations. J Rheumatol 30:585\u2013593","journal-title":"J Rheumatol"},{"key":"2261_CR28","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3899\/jrheum.120842","volume":"40","author":"N Solari","year":"2013","unstructured":"Solari N, Palmisani E, Consolaro A, Pistorio A, Lanni S, Dalpr\u00e0 S et al (2013) Predictors of achievement of inactive disease in children with juvenile idiopathic arthritis treated with Etanercept. J Rheumatol 40:192\u2013200","journal-title":"J Rheumatol"},{"key":"2261_CR29","first-page":"688","volume":"26","author":"S Nielsen","year":"2008","unstructured":"Nielsen S, Ruperto N, Gerloni V, Simonini E, Cortis E, Lepore L et al (2008) Preliminary evidence that etanercept may reduce radiographic progression in juvenile idiopathic arthritis. Clin Exp Rheumatol 26:688\u2013692","journal-title":"Clin Exp Rheumatol"},{"key":"2261_CR30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/ard.2008.099382","volume":"68","author":"JS Smolen","year":"2009","unstructured":"Smolen JS, Aletaha D, Steiner G (2009) Does damage cause inflammation? Revisiting the link between joint damage and inflammation. Ann Rheum Dis 68:159\u2013162","journal-title":"Ann Rheum Dis"},{"key":"2261_CR31","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/1759720X11413630","volume":"4","author":"NM Ruth","year":"2012","unstructured":"Ruth NM, Passo MH (2012) Juvenile idiopathic arthritis: management and therapeutic options. Ther Adv Musculoskelet Dis 4:99\u2013110","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"2261_CR32","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/rheumatology\/kep383","volume":"49","author":"JA Ellis","year":"2010","unstructured":"Ellis JA, Munro JE, Ponsonby AL (2010) Possible environmental determinants of juvenile idiopathic arthritis. Rheumatology (Oxford) 49:411\u2013425","journal-title":"Rheumatology (Oxford)"},{"key":"2261_CR33","doi-asserted-by":"crossref","first-page":"A319","DOI":"10.1016\/j.autrev.2009.11.018","volume":"9","author":"Y Berkun","year":"2010","unstructured":"Berkun Y, Padeh S (2010) Environmental factors and the geoepidemiology of juvenile idiopathic arthritis. Autoimmun Rev 9:A319\u2013A324","journal-title":"Autoimmun Rev"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-013-2261-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-013-2261-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-013-2261-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T15:42:18Z","timestamp":1562946138000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-013-2261-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,19]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["2261"],"URL":"https:\/\/doi.org\/10.1007\/s10067-013-2261-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,19]]}}}